Osiris shrinks (OSIRonline.org) losses in fourth quarter - Birmingham Business Journal
The Columbia company reported a net loss of $7.8 million for the period ending Dec. 31, compared with a net loss of $21.6 million during the same period in 2007. Research and development expenses were lower during the fourth quarter compared with
Source: www.bizjournals.com
Know Your Options When Investing in Biotech Stocks - Seekingalpha.com
Investing in biotechnology stocks is certainly not for the timid or weak at heart. Stocks in the industry trade with perhaps the highest volatility in the market and move based on binary events. The ultimate of binary events for a biotech stock is
Source: seekingalpha.com
Osiris Therapeutics Q4 Loss Narrows - Update - RTT News
(RTTNews) - Friday, Osiris Therapeutics Inc. (OSIR: News ), a stem cell therapeutic company, reported a narrower loss for the fourth quarter, backed by an increase in quarterly revenues and lower expenses. The Columbia, Maryland-based company
Source: www.rttnews.com
Osiris Therapeutics to Present at Barclays Capital Global Healthcare - StreetInsider.com
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NASDAQ: OSIR ), the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas
Source: www.streetinsider.com